A prospective comparative clinical study to identify efficacy and safety of pitavastatin in patients with a metabolic syndrome.
Phase of Trial: Phase IV
Latest Information Update: 01 May 2015
At a glance
- Drugs Pitavastatin (Primary)
- Indications Metabolic syndrome
- Focus Therapeutic Use
- Acronyms ProPit
- Sponsors JW Pharmaceutical
- 10 Jun 2017 Biomarkers information updated
- 29 Mar 2012 Actual patient number (187) added as reported by ClinicalTrials.gov.
- 29 Mar 2012 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.